Several novel diazadioxa ferrocenyl derivatives have been prepared along with their previously unknown electroactive precursor [(C(5)H(5))Fe(C(5)H(4)CH(2)N(CH(3))(CH(2))(2)OCH(2)-)](2) (2). Di-N,N'-protonated and -methylated species [2(H)(2)][X](2) (3a-c) (X = CF(3)SO(3), BF(4), PF(6)) and [2(Me)(2)][CF(3)SO(3)](2) (5), and N-H-N monoprotonated species [2H][X] (4a-c) have been isolated in high yield. The efficient syntheses of compounds [2Na][PF(6)] (6), [2Cu][CF(3)SO(3)] (7), [2Ag][CF(3)SO(3)] (8), and [2MCl(2)] (M = Zn, Hg) (9, 10) are reported. The crystal structure of complex 7 has been determined by X-ray analysis at 180 K. Crystal data: monoclinic P2(1)/c, with a = 11.511(2) Å, b = 19.613(2) Å, c = 14.493(2) Å, beta = 88.32(2) degrees, V = 3273.2(1) Å(3), Z = 4; R = 0.034, R(w) = 0.039 for 3379 observations and 407 variable parameters. The copper(I) atom, bound to the two O and two N atoms of the ferrocenyl ligand, is in a very distorted tetrahedral geometry with a large N(1)CuN(2) angle (163.1(2) degrees ). In cyclic voltammetry, 4a-c undergo two quasi-reversible (Fe(II)/Fe(III)) redox processes at 0.1 V s(-)(1). Electrochemical studies of 3a-c, 5, 7, and 8 show that diprotonation and dialkylation of 2 or complexation of a Cu (Ag) salt induces an anodic shift ranging from 240 to 110 mV. Chemical oxidation of 2 (5 equiv of Ag(I)) produces the cation [2(H)(2)](4+) (11). The quantitative two-step electrochemical oxidation of 2 at controlled potential in CH(3)CN also leads to 11: an ECE mechanism, in which the diprotonated species plays a key role, is proposed. Mössbauer data of 2, 3c, 6, 7, 8, and 11 are also presented.
No takes yet. Share an insight, caveat, or question.
Delavaux‐Nicot et al. (1997) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: